1-5 of 5
Marienn Reti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel, Closed-Line Mini Extracorporeal Photopheresis (ECP) Technique Using the Therakos TM CellEx TM Photopheresis System, Developed for Patients with Contraindications Against Conventional ECP Therapy

Andrea Várkonyi, Krisztián Kállay, Katalin Dobos, Szabolcs Tasnády, Péter Reményi, Marienn Reti
Journal: Blood
Blood (2023) 142 (Supplement 1): 6945.
https://doi.org/10.1182/blood-2023-181818
Published: 2023
Journal Articles

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

PAUL Coppo, Michaël Bubenheim, Ygal Benhamou, Linus A. Voelker, Paul T. Brinkkoetter, Lucas Kühne, Paul N. Knoebl, Maria Eva Mingot, Maria Cristina Pascual Izquierdo, Javier De La Rubia, Julio Del Rio Garma, Shruti Chaturvedi, Camila Masias, Marshall Mazepa, X. Long Zheng, Gyorgy Sinkovits, Marienn Reti, Christopher J. Patriquin, Katerina Pavenski, Tiago Boechat, Joao Farias, Eduardo Flavio Oliveira Ribeiro, Michaela Larissa Lobo de Andrade, Agnès Veyradier, Bérangère Joly, Sr., Raïda Bouzid, Kazuya Sakai, Masanori Matsumoto, Ilaria Mancini, Pasquale Agosti, Flora Peyvandi, Matthew James Stubbs, Amjad Hmaid, Sobia Sharif, Tina Dutt, Spero Cataland, Bernhard Lammle, Marie Scully
Journal: Blood
Blood (2023) 142 (Supplement 1): 2636.
https://doi.org/10.1182/blood-2023-179316
Published: 2023
Journal Articles

Caplacizumab Therapy in Immune Thrombotic Thrombocytopenic Purpura

Marienn Réti, György Sinkovits, Andrea Várkonyi, Ágnes Király, Zita Farkas, Luca Bogsch, Andreea-Adela Icleanu, Tamás Masszi, István Vályi-Nagy, Zoltán Prohászka, Péter Pál Reményi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5436.
https://doi.org/10.1182/blood-2023-186633
Published: 2023
Journal Articles

Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Elien Roose, An-Sofie Schelpe, Edwige Tellier, György Sinkovits, Bérangère S. Joly, Charlotte Dekimpe, Gilles Kaplanski, Maelle Le Besnerais, Ilaria Mancini, Tanja Falter, Charis Von Auer, Hendrik B. Feys, Marienn Reti, Heidi Rossmann, Aline Vandenbulcke, Inge Pareyn, Jan Voorberg, Andreas Greinacher, Ygal Benhamou, Hans Deckmyn, Rob Fijnheer, Zoltan Prohászka, Flora Peyvandi, Bernhard Lämmle, Paul Coppo, Simon F. De Meyer, Agnès Veyradier, Karen Vanhoorelbeke
Journal: Blood
Blood (2020) 136 (3): 353–361.
https://doi.org/10.1182/blood.2019004221
Published: 2020
Includes: Supplemental data
Journal Articles

Description of the First Cases with ADAMTS13 Mutations in Hungary

Marienn Réti, MD, György Sinkovits, MD, Orsolya Cseprekál, MD PhD, Dorottya Csuka, PhD, Ágnes Szilágyi, PhD, Zita Farkas, MD, Zsolt Klucsik, MD, Attila Szederjesi, MSC, László Wágner, MD Prof, György Reusz, MD Prof, Johanna A. Kremer Hovinga, MD Prof, János Rigó, MD Prof, Tamas Masszi, MD Prof., Zoltan Prohászka, MD Prof
Journal: Blood
Blood (2018) 132 (Supplement 1): 5003.
https://doi.org/10.1182/blood-2018-99-118327
Published: 2018